Director R&D Aliri Loos, Nord-Pas-de-Calais, France
The advent of multi-omics is allowing to probe the more complex and transient molecular changes that underpin the course of disease and response to treatment. Spatial omics approaches have the advantage of dissecting cellular dynamics and heterogeneity, whereas traditional bulk technologies are limited to individual/population-level investigation. This has far-reaching implications for drug development giving us the potential to spot a new drug target in the context of the disease, anticipate toxicity and decipher drug mechanism of action at the single cell level. This symposium will adress the following: - Leveraging molecular imaging to understand drug efficay and impact - Creating strategies to further advance spatial biomarker in drug development - Understanding trends for patient selection in clinical trials
Learning Objectives:
Understand the application of multi-omics techniques in deciphering complex disease processes
Explore the advantages of spatial omics in dissecting cellular dynamics and heterogeneity.
Gain insights into how these techniques can impact drug development.
Discover strategies for advancing spatial biomarkers in drug development.
Comprehend trends in patient selection for clinical trials.